{
    "paper_id": "d7d7e011d8ac21019e957defc13bf8cd12162c66",
    "metadata": {
        "title": "Supplementary Table 1. Selection of host-directed therapies for chronic HBV, HCV and HIV infections. Infection Strategy Agent Status of development Ref Chronic",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "DNA-based genetic vaccines (with Proof-of-concept study 11, 12 In format provided by Kaufmann et al. ",
            "cite_spans": [
                {
                    "start": 56,
                    "end": 59,
                    "text": "11,",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 60,
                    "end": 62,
                    "text": "12",
                    "ref_id": "BIBREF11"
                }
            ],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Blank",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "J Hepatol",
            "volume": "65",
            "issn": "",
            "pages": "483--489",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jhep.2016.04.013"
                ]
            }
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Bogomolov",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "J Hepatol",
            "volume": "65",
            "issn": "",
            "pages": "490--498",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jhep.2016.04.016"
                ]
            }
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Restoration of T cell function in chronic hepatitis B patients upon treatment with interferon based combination therapy",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "De Niet",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "J Hepatol",
            "volume": "64",
            "issn": "",
            "pages": "539--546",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jhep.2015.10.013"
                ]
            }
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Combination of Tenofovir Disoproxil Fumarate and Peginterferon alpha-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Marcellin",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Gastroenterology",
            "volume": "150",
            "issn": "",
            "pages": "134--144",
            "other_ids": {
                "DOI": [
                    "10.1053/j.gastro.2015.09.043"
                ]
            }
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-coinfected patients on cART including tenofovir: EMVIPEG study",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Miailhes",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J Hepatol",
            "volume": "61",
            "issn": "",
            "pages": "761--769",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jhep.2014.05.030"
                ]
            }
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "AASLD guidelines for treatment of chronic hepatitis B",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "A"
                    ],
                    "last": "Terrault",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Hepatology",
            "volume": "63",
            "issn": "",
            "pages": "261--283",
            "other_ids": {
                "DOI": [
                    "10.1002/hep.28156"
                ]
            }
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Approved by the Guidelines Review Committee. In: Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. World Health Organization",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Who",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Guidelines",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "Z"
                    ],
                    "last": "Xu",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "PloS one",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1371/journal.pone.0002565"
                ]
            }
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Backes",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Vaccine",
            "volume": "34",
            "issn": "",
            "pages": "923--932",
            "other_ids": {
                "DOI": [
                    "10.1016/j.vaccine.2015.12.060"
                ]
            }
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Boni",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Virol",
            "volume": "81",
            "issn": "",
            "pages": "4215--4225",
            "other_ids": {
                "DOI": [
                    "10.1128/jvi.02844-06"
                ]
            }
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Increase of Plasma IL-12/p40 Ratio Induced by the Combined Therapy of DNA Vaccine and Lamivudine Correlates with Sustained Viremia Control in CHB Carriers",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Im",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "K"
                    ],
                    "last": "Yoon",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "C"
                    ],
                    "last": "Sung",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Immune Netw",
            "volume": "9",
            "issn": "",
            "pages": "20--26",
            "other_ids": {
                "DOI": [
                    "10.4110/in.2009.9.1.20"
                ]
            }
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Gene Ther",
            "volume": "13",
            "issn": "",
            "pages": "1110--1117",
            "other_ids": {
                "DOI": [
                    "10.1038/sj.gt.3302751"
                ]
            }
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Krebs",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Gastroenterology",
            "volume": "145",
            "issn": "",
            "pages": "456--465",
            "other_ids": {
                "DOI": [
                    "10.1053/j.gastro.2013.04.047"
                ]
            }
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Heim",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Nat Rev Immunol",
            "volume": "13",
            "issn": "",
            "pages": "535--542",
            "other_ids": {
                "DOI": [
                    "10.1038/nri3463"
                ]
            }
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "J"
                    ],
                    "last": "Muir",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J Hepatol",
            "volume": "61",
            "issn": "",
            "pages": "1238--1246",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jhep.2014.07.022"
                ]
            }
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "The Cyclophilin Inhibitor Debio 025 Combined with PEG IFN alpha 2a Significantly Reduces Viral Load in Treatment-Naive Hepatitis C Patients",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Flisiak",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Hepatology",
            "volume": "49",
            "issn": "",
            "pages": "1460--1468",
            "other_ids": {
                "DOI": [
                    "10.1002/hep.22835"
                ]
            }
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hopkins",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J Hepatol",
            "volume": "57",
            "issn": "",
            "pages": "47--54",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Flisiak",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Hepatology",
            "volume": "47",
            "issn": "",
            "pages": "817--826",
            "other_ids": {
                "DOI": [
                    "10.1002/hep.22131"
                ]
            }
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Cyclophilin inhibitors: an emerging class of therapeutics for the treatment of chronic hepatitis C infection",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hopkins",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Gallay",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Viruses",
            "volume": "4",
            "issn": "",
            "pages": "2558--2577",
            "other_ids": {
                "DOI": [
                    "10.3390/v4112558"
                ]
            }
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Lawitz",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Antiviral Res",
            "volume": "89",
            "issn": "",
            "pages": "238--245",
            "other_ids": {
                "DOI": [
                    "10.1016/j.antiviral.2011.01.003"
                ]
            }
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Hsu",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J Clin Invest",
            "volume": "122",
            "issn": "",
            "pages": "2871--2883",
            "other_ids": {
                "DOI": [
                    "10.1172/jci63539"
                ]
            }
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "C"
                    ],
                    "last": "Tsai",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J Clin Invest",
            "volume": "122",
            "issn": "",
            "pages": "2884--2897",
            "other_ids": {
                "DOI": [
                    "10.1172/jci63455"
                ]
            }
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Van Der Ree",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Antiviral Res",
            "volume": "111",
            "issn": "",
            "pages": "53--59",
            "other_ids": {
                "DOI": [
                    "10.1016/j.antiviral.2014.08.015"
                ]
            }
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Maraviroc: a review of its use in HIV infection and beyond",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Woollard",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "D"
                    ],
                    "last": "Kanmogne",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Drug Des Devel Ther",
            "volume": "9",
            "issn": "",
            "pages": "5447--5468",
            "other_ids": {
                "DOI": [
                    "10.2147/DDDT.S90580"
                ]
            }
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "M"
                    ],
                    "last": "Asmuth",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J Infect Dis",
            "volume": "201",
            "issn": "",
            "pages": "1686--1696",
            "other_ids": {
                "DOI": [
                    "10.1086/652420"
                ]
            }
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Nat Med",
            "volume": "22",
            "issn": "",
            "pages": "807--811",
            "other_ids": {
                "DOI": [
                    "10.1038/nm.4124"
                ]
            }
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "G"
                    ],
                    "last": "Deeks",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Mol Ther",
            "volume": "5",
            "issn": "",
            "pages": "788--797",
            "other_ids": {
                "DOI": [
                    "10.1006/mthe.2002.0611"
                ]
            }
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Antibody-modified T cells: CARs take the front seat for hematologic malignancies",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "V"
                    ],
                    "last": "Maus",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Grupp",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "L"
                    ],
                    "last": "Porter",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "H"
                    ],
                    "last": "June",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Blood",
            "volume": "123",
            "issn": "",
            "pages": "2625--2635",
            "other_ids": {
                "DOI": [
                    "10.1182/blood-2013-11-492231"
                ]
            }
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta genemodified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus -infected subjects",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "T"
                    ],
                    "last": "Mitsuyasu",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Blood",
            "volume": "96",
            "issn": "",
            "pages": "785--793",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Roberts",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Blood",
            "volume": "84",
            "issn": "",
            "pages": "2878--2889",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Scholler",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Sci Transl Med",
            "volume": "4",
            "issn": "",
            "pages": "132--153",
            "other_ids": {
                "DOI": [
                    "10.1126/scitranslmed.3003761"
                ]
            }
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells",
            "authors": [
                {
                    "first": "O",
                    "middle": [
                        "O"
                    ],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "94",
            "issn": "",
            "pages": "11478--11483",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Zhen",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Mol Ther",
            "volume": "23",
            "issn": "",
            "pages": "1358--1367",
            "other_ids": {
                "DOI": [
                    "10.1038/mt.2015.102"
                ]
            }
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Effect of therapeutic HIV recombinant poxvirus vaccines on the size of the resting CD4+ T-cell latent HIV reservoir",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Persaud",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "AIDS",
            "volume": "25",
            "issn": "",
            "pages": "2227--2234",
            "other_ids": {
                "DOI": [
                    "10.1097/QAD.0b013e32834cdaba"
                ]
            }
        }
    },
    "ref_entries": {
        "TABREF0": {
            "text": "Phase Ib/IIa study of patients with chronic HBV -HDV co-infection; orphan drug status by the EMA and the PegIFN\u03b1-2a for treatment of adult patients with HBeAg positive or negative chronic hepatitis B, compensated liver disease, liver inflammation and evidence of viral replication; Intron A for chronic hepatitis B in patients 1year of age or older with compensated liver disease",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Cell-based immunotherapy CAR-redirected T cells: e.g. CD4\u03b6Phase II randomized study; preclinical study of CAR-engrafted T-cells co-expressing shRNAs targeting CCR5 and the HIV-1 genome Phase I clinical trial in young adults on effective HAART In format provided by Kaufmann et al. (doi:10.1038/nrd.2017.162) SUPPLEMENTARY INFORMATION NATURE REVIEWS | DRUG DISCOVERY www.nature.com/nrd",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}